BEVERLY, Mass. and TORONTO, April 18, 2018 -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will release its financial results for the three months and year ended December 31, 2017 before market open on Wednesday, April 25, 2018. The press release, with accompanying financial information, will be posted on the Company’s website at www.hamiltonthorne.com and on www.sedar.com.
The Company will follow with a conference call on the same day, at 11:00 a.m. EDT to review highlights of results. All interested parties are welcome to join the conference call by dialing toll free 1-855-223-7309 in North America, or 647-788-4929 from other locations, and requesting Conference ID 3284638. A recording of the call will be available on Hamilton Thorne’s website shortly after the call.
About Hamilton Thorne Ltd. (www.hamiltonthorne.com)
Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.
Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.
For more information, please contact:
David Wolf, President & CEO Michael Bruns, CFO
Hamilton Thorne Ltd. Hamilton Thorne Ltd.
978-921-2050 978-921-2050
[email protected] [email protected]


BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Google Expands Gemini Enterprise With AI Tools for Legal Sector
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Luxshare Shares Rise as First-Half Profit Jumps 18%
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Jefferies Names AMEC Top China Semiconductor Equipment Pick
OpenAI AI Agent Swarm Behind Hugging Face Hack
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 



